Dopo l'orario di chiusura: 8.37 0.02 +0.24%

Cybin Inc (CYBN)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Cybin Inc Borsa (CYBN) Ultime notizie

Cybin Inc (CYBN)

Cybin Inc Borsa (CYBN) Ultime notizie

Cybin Provides Corporate Update and Highlights Positive Regulato - GuruFocus

Cybin Advances Phase 3 Program Amid Positive Regulatory Signals - TipRanks

# Cybin begins phase 3 trials for depression treatment CYB003 - Investing.com Australia

Cybin Provides Corporate Update, Highlights Positive Regulatory Signals For Psychedelic Therapeutics - marketscreener.com

# Cybin begins phase 3 trials for depression treatment CYB003 By Investing.com - Investing.com India

Cybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics | CYBN Stock News - GuruFocus

Should You Buy Polkadot While It's Under $5? - The Globe and Mail

Cybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics - The Globe and Mail

Prediction: This Company Will Be the Most Valuable AI Stock in 2026 - The Globe and Mail

Billionaire Bill Ackman Just Scooped Up Shares of This Unstoppable Stock - The Globe and Mail

Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Per - GuruFocus

Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference | CYBN Stock News - GuruFocus

Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference - Business Wire

Cybin to Participate in the 2025 Psychedelic Science Conference - GuruFocus

Cybin to Participate in the 2025 Psychedelic Science Conference | CYBN Stock News - GuruFocus

Crypto's hottest new trend: publicly traded companies buying bunches of bitcoin - The Globe and Mail

(CYBN) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Cybin, Inc: The Strategic Approach to Formulating a Successful CYB003 Launch - Smartkarma

Cybin (CYBN) Gains Positive Outlook from Lucid Capital | CYBN St - GuruFocus

Market Analysis: June 6th, 2025 - The Globe and Mail

lucid capital markets initiates buy rating on cybin stock - Investing.com Australia

lucid capital markets initiates buy rating on cybin stock By Investing.com - Investing.com South Africa

Cybin (CYBN) Gains Positive Outlook from Lucid Capital | CYBN Stock News - GuruFocus

Cybin secures U.S. patent for program targeting generalized Anxiety disorder and depression - Proactive Investors

Cybin, Inc.The Strategic Approach to Formulating a Successful CYB003 Launch - Smartkarma

Why MongoDB Stock Popped Today - The Globe and Mail

Psychedelic Drugs Market 2025 | Growth Trends, Mental Health - openPR.com

Cybin Announces Additional U.S. Patent Supporting its CYB004 Program in Phase 2 Development for Generalized Anxiety Disorder - BioSpace

Cybin secures patent for anxiety disorder treatment CYB004 - Investing.com

Cybin Granted Additional US Patent for Potential Anxiety Disorder Treatments - marketscreener.com

Cybin secures patent for anxiety disorder treatment CYB004 By Investing.com - Investing.com Canada

Cybin Secures U.S. Patent for CYB004 Program in Anxiety Disorder Treatment - TipRanks

Cybin (CYBN) Secures U.S. Patent for CYB004 Program | CYBN Stock News - GuruFocus

Cybin Announces Additional U.S. Patent Supporting its CYB004 Pro - GuruFocus

Cybin taps Thermo Fisher for U.S. manufacturing of CYB003 - MSN

Transcript : Cybin Inc.Special Call - marketscreener.com

(CYBN) Proactive Strategies - news.stocktradersdaily.com

Prediction: Dogecoin Will Plummet to New Lows by the End of the Year. Here's Why. - The Globe and Mail

Cboe Canada Single Security - Cboe Global Markets

Billionaire CEO Jamie Dimon Just Delivered a Stark Warning to the Market. Here Are 3 Things Investors Should Do. - The Globe and Mail

This Chinese Robotaxi Stock Could Be an Even Better Buy Than Tesla Before June - The Globe and Mail

Cybin CEO to Discuss Strategic Advances at Upcoming Fireside Chat - TipRanks

Cybin to Participate in Water Tower Research Fireside Chat on May 29, 2025 - BioSpace

Cybin to Participate in Water Tower Research Fireside Chat on May 29, 2025 | CYBN Stock News - GuruFocus

Cybin CEO Reveals Latest on Phase 3 Psychedelics Program and FDA Developments in Exclusive Analyst Chat - Stock Titan

Cybin Engages Thermo Fisher Scientific To Provide U.S.-Based Manufacturing for Its CYB003 Program - Technology Networks

Cybin Applauds FDA Commissioner Dr. Martin Makary's Call to Acce - GuruFocus

Cybin Applauds FDA Commissioner Dr. Martin Makary's Call to Accelerate and Prioritize Research on Psychedelic Therapeutics | CYBN Stock News - GuruFocus

Cybin Applauds FDA Commissioner Dr. Martin Makary’s Call to Accelerate and Prioritize Research on Psychedelic Therapeutics - Yahoo Finance

Simile a CYBN